View:
Download DOC
Download PDF
Download XLS
Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 8, 2024
Accession Number:
0001193125-24-088114
Submission Type:
POS AM
CIK:
0001426332
Company Name:
NGM BIOPHARMACEUTICALS INC
File Number:
333-272509